Morphology-Based Rating of Egg Development Potential

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 2R44HD037317-02
Agency Tracking Number: 1R43HD037317-01A1
Amount: $1,141,780.00
Phase: Phase II
Program: SBIR
Awards Year: 2005
Solicitation Year: 2005
Solicitation Topic Code: N/A
Solicitation Number: PHS2005-2
Small Business Information
CAMBRIDGE RESEARCH AND INSTRUMENTATION
Cambridge Research, And Instrumentation, Inc., Woburn, MA, 01801
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 CLIFFORD HOYT
 (781) 935-9099
 CHOYT@CRI-INC.COM
Business Contact
 GEORGE ABE
Phone: (781) 935-9099
Email: GABE@CRI-INC.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The objective of this Phase II project is to develop a more effective tool for assessing the development potential of human oocytes and to reduce the emotional, health, and financial costs of low IVF success rates, presently approximately 25% per cycle. To compensate for these low rates, as many as three or more embryos are transferred to the mother-this practice is a leading cause of multiple and often premature births. Low success rates also lead to multiple, emotionally draining and expensive interventions. An ability to select high quality oocytes is critical to achieving successful outcomes. The main premise of this application is that reliable quantitative analysis of oocyte structures can improve IVF techniques, and proposes to apply to this task a new type of microscope that measures birefringence, an optical property exhibited in many cellular structural elements. Compared to images provided by traditional Hoffman or DIG optics presently used for oocyte assessment, non-invasive birefringence imaging using CRI's unique liquid crystal polarized light microscope dramatically and quantitatively highlights the meiotic spindle and other cellular structures by measuring birefringence retardation at each image point in the field of view. Phase I demonstrated that birefringence imaging of oocyte structures provides information that correlates significantly with embryo development and, ultimately, clinical outcome. Spindle visualization was also shown to be useful in assessing viability of cryopreserved oocytes, another critical and otherwise unsolved problem. Phase II specific aims include extending functionality to allow quantitative measurement of birefringence in three dimensions, adding features to make operation more suitable to the clinical IVF setting, developing an appropriately sized and treated glass-bottom dish, developing software tools and algorithms that extract additional quantitative information about viability and condition, and working with three beta-sites to test systems and provide vital feedback on effectiveness and operation.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government